Malaysia will continue studying new vaccine for dengue


PETALING JAYA: While a vaccine produced by Sanofi Pasteur has been the first in the world to be licensed for dengue prevention, Malaysia will continue to study its suitability for use in the country.

The Health Ministry is still poring over the data of the anti-dengue vaccine by the French-based company, as the dengue subtypes in its vaccine trials are different from Malaysia’s.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Health , Dengue , Health , vaccine

   

Next In Nation

Changing of the Guard resumes at Istana Negara
Labuan MP stands firm in backing Anwar
Reconsider GST implementation, urges Johor MB
Public warned of fake health product ads
Smokers start before age 18
Praying for good health and year
Drunkard attempts to snatch submachine gun from cop
‘Getting addicted is not as straightforward as consuming a substance’
Sarawak’s progress thanks to political stability, says DPM
Total makeover needed to kick the habit

Others Also Read